YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	Single-cell multi-omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK-positive lung cancer	CANCER COMMUNICATIONS
2025	Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitis	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2025	2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome	JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY
2025	Association of Postprocedure Ankle-Brachial Index With Outcomes Following Drug-Coated Balloon Angioplasty in Femoropopliteal Artery Disease	AMERICAN JOURNAL OF CARDIOLOGY
2025	Novel Risk Score for 30-Day Adverse Events Following Colonoscopy in Older Adults	GUT AND LIVER
2025	Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma	ANNALS OF ONCOLOGY
2025	Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution	CANCER DISCOVERY
2025	Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2025	Evaluating the efficacy of a novel hemostatic powder compared with traditional treatments in nonvariceal upper GI bleeding: a multicenter, randomized, noninferiority study	GASTROINTESTINAL ENDOSCOPY
2025	Statin use and liver-related prognosis among patients with MASLD	JHEP REPORTS
2025	Newly designed flared-end covered versus uncovered self-expandable metallic stents for palliation of malignant colorectal obstruction: a randomized, prospective study	INTESTINAL RESEARCH
2025	Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas	EUROPEAN JOURNAL OF ENDOCRINOLOGY
2025	Physical activity levels among long-term cancer survivors of more than 5 years: a propensity score matching analysis	SUPPORTIVE CARE IN CANCER
2025	Clinical Significance of Various Pathogens Identified in Patients Experiencing Acute Exacerbations of COPD: A Multi-center Study in South Korea	TUBERCULOSIS AND RESPIRATORY DISEASES
2025	Bioelectrical impedance analysis parameters are superior to liver enzymes in predicting metabolic dysfunction-associated steatotic liver disease in young adults	INTERNAL AND EMERGENCY MEDICINE
2025	Distal Radial Access and Women: Implications for Access Site Outcomes in Coronary Procedures	JOURNAL OF THE AMERICAN HEART ASSOCIATION
2025	Feasibility of Distal Radial Access in High Bleeding Risk Patients Who Underwent Percutaneous Coronary Intervention	KOREAN CIRCULATION JOURNAL
2025	[68Ga]-DOTATOC PET/CT Volumetric Parameters Reflect Metastatic Potential in Pancreatic Neuroendocrine Tumors	CANCERS
2025	Clinical Utility of Serum sCD200/sCD200R Ratios in Predicting Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	JOURNAL OF CLINICAL MEDICINE
2025	Stereotactic body radiotherapy for early‑stage non‑small cell lung cancer: Comprehensive analysis of outcomes and recurrence from a single‑center experience	ONCOLOGY LETTERS